Equities

Yubo International Biotech Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
YBGJ:QBB

Yubo International Biotech Ltd

Actions
  • Price (USD)0.0115
  • Today's Change0.00 / 0.00%
  • Shares traded11.00
  • 1 Year change-80.57%
  • Beta-1.0610
Data delayed at least 15 minutes, as of Jan 26 2026 19:43 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Yubo International Biotech Ltd, formerly Magna-Lab Inc, is a holding company primarily operating through its subsidiary. The Company focuses on the research and development and application of endometrial stem cells and offers its products and services under the brand VIVCELL. The Company’s product offerings include healthcare products for respiratory system, skincare products, hair care products, healthy beverages and male and female personal care products. The Company also offers stem cell related services including cell testing and health management consulting services.

  • Revenue in USD (TTM)-20.00
  • Net income in USD-1.23m
  • Incorporated1991
  • Employees18.00
  • Location
    Yubo International Biotech LtdRoom 105, Building 5, 31 Xishiku AvenueBEIJING 100026ChinaCHN
  • Phone+86 1 066155141
  • Fax+1 5 165951159
  • Websitehttps://www.yubogroup.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Carisma Therapeutics Inc52.63m8.04m1.61m46.000.2047--0.16870.03060.18810.18811.26-0.02082.17----1,144,174.0033.09-26.5851.48-30.35----15.28-169.12--------31.59--30.39---1.99--
Galera Therapeutics Inc0.00-8.99m1.66m3.00---------0.1302-0.13020.00-1.940.00----0.00-129.27-96.94-145.04-116.42------------34.30------67.91------
Clearmind Medicine Inc0.00-3.86m1.68m----0.1485-----30.64-30.640.007.540.00-------57.83-128.70-178.71-360.04------------0.5987------26.60------
Agentix Corp0.00-655.59k1.68m-----------0.0164-0.01640.00-0.08530.00-------746.86-----------------7.07--------3.09------
Hcw Biologics Inc422.03k-22.21m1.76m36.00------4.16-13.96-13.960.2716-0.80380.0162--1.2411,723.06-46.35-53.89---66.1020.00---2,855.77-545.79---42.261.45---9.68---20.12---29.10--
Zyversa Therapeutics Inc0.00-25.70m1.83m7.00---------4.46-4.460.00-1.450.00----0.00-251.13-----------------14.60--------91.14------
Bluejay Diagnostics Inc0.00-20.07m1.89m7.00--0.2963-----134.42-134.420.009.010.00----0.00-103.46-70.71-124.04-82.92-------12,694.84----0.0028-------110.38--119.51--
Yubo International Biotech Ltd-20.00-1.23m1.96m18.00---------0.0099-0.00990.00-0.0098-0.00002-0.0005---1.11-105.87--------------0.2394-------99.43---48.55------
CDT Equity Inc0.00-20.70m1.99m6.00--0.3223-----473.79-473.790.003.350.00----0.00-358.56-----------------16.000.2881-------3,227.48------
ABPRO Holdings Inc0.00-22.04m2.00m6.00---------24.37-24.370.00-6.040.00----0.00-467.23-----------------4.82----50.00---48.72------
Bone Biologics Corp0.00-3.95m2.14m2.00--0.356-----7.30-7.300.003.350.00----0.00-75.76-86.22-80.46-561.06------------0.00------18.15------
Azitra Inc0.00-11.12m2.15m12.00--0.4914-----5.49-5.490.000.40660.00----0.00-157.91---203.88--------------0.1197---98.91--29.05------
CNS Pharmaceuticals Inc0.00-13.07m2.15m4.00--0.2006-----130.83-130.830.0017.250.00----0.00-135.60-153.00-197.11-237.57------------0.0031------21.18---26.93--
Cardio Diagnostics Holdings Inc15.79k-6.55m2.32m13.00--0.2752--146.87-4.07-4.070.00974.610.0024--1.251,214.62-98.75---104.31-------41,495.31-----440.220.00--104.39---0.079------
Purminds Enterprises Inc0.00-77.46k2.36m0.00--0.0654-----0.1832-0.18320.000.76460.00-------26.19-620.48-66.38-------------6.290.00-------13.29------
Data as of Jan 26 2026. Currency figures normalised to Yubo International Biotech Ltd's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.